An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting
Risk Management and Healthcare Policy · 2026-02 · Volume 19 · 1-13
DOI: 10.2147/rmhp.s558872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Risk Management and Healthcare Policy, 2026-02. Verfasst von Alessandro Morabito und 24 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Department, Division of Thoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
This study aims to identify and reduce risks that could negatively impact patient safety and organizational aspects related to the different phases of anticancer drug therapy for lung cancer patients in the Day Hospital (DH) care.
Methods
From April 2023 until February 2024, a team of multi-disciplinary healthcare professionals of the National Cancer Institute of Naples, Italy, used a modified Delphi approach to identify the care process, the main activities and related risk factors. The severity of these harms and the probability of their occurrence were assessed by applying a 5×5 semi-quantitative ISO 31000:2018 (ISO 31000) risk matrix. Multiple improvement actions were identified and adopted by the team to reduce the risks to acceptable levels.
Results
Nine main activities, 19 correlated potential risks (10 risks for patient safety domain; 53.0%) (9 risks for organizational area; 47.0%) and 19 mitigation measures were identified. The highest risk levels were recognized in the organizational area for: (i) DH Outpatient Visits, due to delays in patients check-in or lab test results or problems with the prescription software; (ii) anticancer drugs administration, for the unavailability of chemotherapy chairs or lack of dedicated nursing staff. Conversely, risk levels for patient safety area were low overall, because several control measures were already in place. Once the mitigation measures were implemented, a new semi-quantitative risk analysis was performed. Risk levels for organizational area changed from a 44.4% to 0.0% in high level, from 44.4% to 67.0% in moderate level, and from 11.2% to 33.0% in minor level. Risk levels for safety areas did not modify for high level (10.0%), but changed from 50.0% to 10.0% in moderate level and increased from 40.0% to 80.0% in minor level.
Conclusion
ISO 31000 risk management framework applied to lung cancer DH care could improve both organizational and safety objectives in oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Department, Division of Thoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
- Department of Strategic Health Services, Pharmacy, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
- Department of Strategic Health Services, Hospital Direction, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
- Department of Precision Medicine, Division of Medical Oncology, Università of Campania "Luigi Vanvitelli", Napoli, Italy.
- Department of Finance and Management, Wroclaw School of Banking Wyzsza Szkoła Bankowa, Wrocalw, Poland.
- Department of Public Health, Università Federico II, Napoli, Italy.
ORCID-Profile: Alessandro Morabito, Giuseppe Caropreso, Simona Damiano, Cira Antonietta Forte, Giacomo Pascarella
Zitieren
APA
Morabito, A., Maiolino, P., D'Auria, S., D'Aniello, R., Sandomenico, C., Montanino, A., Casale, M., Palumbo, G., Sforza, V., Costanzo, R., Esposito, G., Caropreso, G., Manzo, A., Capasso, A., Barba, B., Pannone, C., Campitiello, L., Nardone, A., Triassi, M., …, & Pascarella, G. (2026). An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting. Risk Management and Healthcare Policy, Volume 19, 1-13. https://doi.org/10.2147/rmhp.s558872
Vancouver
Morabito A, Maiolino P, D'Auria S, D'Aniello R, Sandomenico C, Montanino A, et al. An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting. Risk Management and Healthcare Policy. 2026;Volume 19:1-13. doi:10.2147/rmhp.s558872
BibTeX
@article{Morabito2026,
author = {Morabito, Alessandro and Maiolino, Piera and D'Auria, Stefania and D'Aniello, Roberta and Sandomenico, Claudia and Montanino, Agnese and Casale, Marina and Palumbo, Giuliano and Sforza, Vincenzo and Costanzo, Raffaele and Esposito, Giovanna and Caropreso, Giuseppe and Manzo, Anna and Capasso, Arturo and Barba, Bruno and Pannone, Carlo and Campitiello, Loredana and Nardone, Antonio and Triassi, Maria and Damiano, Simona and Forte, Cira Antonietta and Rocco, Amalia and De Feo, Gianfranco and Tracey, Maura and Pascarella, Giacomo},
title = {An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting},
journal = {Risk Management and Healthcare Policy},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/rmhp.s558872}
}
EUVIMED